LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA
PublisherFerrata Storti Foundation
MetadataShow full item record
SponsorsD.M. was supported by the Cooley’s Anemia Foundation, the French Foundation for Rare Diseases, the Région Midi-Pyrénées and ANR (ANR-17-CE14-0036-01 and ANR-17-CE14-0031-01). H.C. and M.-P.R. were supported in part by grants from FRM (DEQ2000326528) and ANR (ANR-13-BSV3-0015-01). This work was also supported by the “Programme des Investissements d’Avenir” ANINFIMIP (ANR-11EQPX-0003).
Keywordiron-refractory iron-deficiency anemia
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85081633777&doi=10.3324%2fHAEMATOL.2019.236133&partnerID=40&md5=694f26f2b388f9a983b9b2fdfb7f2cd0; http://hdl.handle.net/10713/12375